Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib

por Lin, Liping, Huang, Fuxi, Chen, Fang, He, Yan, Hu, Jiazhu, Cao, Xiaolong
Publicado 2018

Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-ce...

por Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Publicado 2016

Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NS...

por Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Publicado 2018

Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors

por Lin, Liping, Zhao, Juanjuan, Kong, Ning, He, Yan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, Cao, Xiaolong
Publicado 2017

Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell...

por Lin, Liping, Zhao, Juanjuan, Hu, Jiazhu, Zou, Guorong, Huang, Fuxi, Han, Jianjun, He, Yan, Cao, Xiaolong
Publicado 2018

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report

por Huang, Senmiao, Li, Dianhe, Huang, Yongye, Lu, Guojie, Tian, Ying, Zhong, Xuefeng, Zheng, Yating, Huang, Mengli, Huang, Fuxi
Publicado 2023

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study

por Fan, Wenzhe, Zhu, Bowen, Yue, Shufan, Zheng, Xinlin, Yuan, Guosheng, Yu, Lei, Huang, Wanchang, Huang, Shugui, Wei, Wenjiang, Li, Fuliang, Huang, Zhen, Tang, Rong, Fan, Huishuang, Li, Zhuoyong, Qiao, Liangliang, Huang, Fuxi, Cheng, Yu, Zhang, Yingqiang, Wu, Yanqin, Zou, Xinhua, Xue, Miao, Wang, Hongyu, Li, Jiaping
Publicado 2022